Mertansine(DM1)
≥98%
- Product Code: 103505
CAS:
139504-50-0
| Molecular Weight: | 738.29 g./mol | Molecular Formula: | C₃₅H₄₈ClN₃O₁₀S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Mertansine (DM1) is primarily used as a potent cytotoxic agent in antibody-drug conjugates (ADCs) for targeted cancer therapy. It is conjugated to monoclonal antibodies that specifically recognize and bind to antigens on the surface of cancer cells. Once the ADC binds to the target cell, it is internalized, and DM1 is released, disrupting microtubule assembly and leading to cell cycle arrest and apoptosis. This targeted approach minimizes damage to healthy cells, making it effective in treating various cancers, including breast cancer and other solid tumors. Its application is particularly notable in drugs like trastuzumab emtansine (T-DM1), used for HER2-positive breast cancer.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿6,500.00 |
+
-
|
| 0.010 | 10-20 days | ฿12,200.00 |
+
-
|
| 0.025 | 10-20 days | ฿24,000.00 |
+
-
|
| 0.100 | 10-20 days | ฿65,000.00 |
+
-
|
Mertansine(DM1)
Mertansine (DM1) is primarily used as a potent cytotoxic agent in antibody-drug conjugates (ADCs) for targeted cancer therapy. It is conjugated to monoclonal antibodies that specifically recognize and bind to antigens on the surface of cancer cells. Once the ADC binds to the target cell, it is internalized, and DM1 is released, disrupting microtubule assembly and leading to cell cycle arrest and apoptosis. This targeted approach minimizes damage to healthy cells, making it effective in treating various cancers, including breast cancer and other solid tumors. Its application is particularly notable in drugs like trastuzumab emtansine (T-DM1), used for HER2-positive breast cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :